Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand - A fail-safe protection against cellular misbehavior

Gene Therapy

Volumn 9, Issue 14, 2002, Pages 955-962

  Fareed, M U ^a   Moolten, F L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gpt; Herpes thymidine kinase; Stem cells; Suicide genes

Indexed keywords

6 THIOXANTHINE; ALANINE AMINOTRANSFERASE; AMINOPTERIN; GANCICLOVIR; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MYCOPHENOLIC ACID; THYMIDINE; THYMIDINE KINASE; XANTHINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL DESTRUCTION; CELL FUNCTION; CELL LINE; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME DEFICIENCY; ESCHERICHIA COLI; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SENSITIZATION; STEM CELL; STEM CELL TRANSPLANTATION; SUICIDE GENE THERAPY;

ANIMALS; APOPTOSIS; CELL LINE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MESODERM; MICE; PRODRUGS; SIMPLEXVIRUS; STEM CELLS; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

ANIMALIA; ESCHERICHIA COLI; MURINAE; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0036319775     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301771     Document Type: Article

References (31)

1. The evolving concept of a stem cell: Entity or function?
2. Epigenetic instability in ES cells and cloned mice
3. Letter (untitled) introducing the 'induced mosaicism' genetic strategy for cancer control
4. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
5. Transduction of the herpes thymidine kinase gene into premalignant murine mammary epithelial cells renders subsequent breast cancers responsive to ganciclovir therapy
6. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
7. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors
8. T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection
9. Preemptive and therapeutic uses of suicide genes for cancer and leukemia
10. Hypoxanthine-guanine phosphoribosyl-transferase deficiency: Lesch-Nyhan syndrome and gout
11. Retrovirally transduced Escherichia coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication
12. In vivo efficacy of HAT therapy against transplantable murine myelomas resistant to purine analogs
13. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells
14. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase
15. Versatile retroviral vectors for potential use in gene therapy
16. In situ use of suicide genes for cancer therapy
17. Drug sensitivity ('suicide') genes for selective cancer chemotherapy
18. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
19. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene
20. Improved artificial death switches based on caspases and FADD
21. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite
22. Cell surface tagging and a suicide mechanism in a single chimeric human protein
23. Cardiac malformation in neonatal mice lacking connexin 43
24. Doubly mutant mice, deficient in connexin 32 and 43, show normal prenatal development of organs where the two gap junction proteins are expressed in the same cells
25. Rescue after intermediate and high-dose methotrexate: Background, rationale, and current practice
26. Hypoxanthine guanine phosphoribosyltransferase activity in primary human osteosarcomas. A rationale for therapy with methotrexate-thymidine rescue?
27. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV infected patients
28. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection
29. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Kiras(G12V)
30. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
31. Preparation and analysis of DNA